NFKB1 and neoplasm: Mutations in NFKB1 have been identified in tumour samples from patients with HL34, and c-Rel encoded by REL (a known causative locus in HL) interacts with NF-kappa-B p105 subunit as a mediator of immune and inflammatory responses4, 35.